Streetbeat News

INVO

INVO Bioscience, Inc.

https://www.invobio.com

Industry

Medical - Devices

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Open

0.86

Mkt cap

3.3M

Volume

124K

High

0.88

P/E Ratio

1.21

52-wk high

3.50

Low

0.82

Div yield

N/A

52-wk low

0.63

The article lists the stocks that gained and lost the most during Friday's mid-day trading session. Among the gainers were Unique Fabricating, Reata Pharmaceuticals, and Bluejay Diagnostics, while the losers included Tonix Pharmaceuticals, Sleep Number Corporation, and Femasys Inc. Avantor shares fell by 9.9% due to worse-than-expected Q2 financial results.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 5:07 pm

Shares of INVO BioScience have resumed trading.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 3:45 pm

Shares of INVO BioScience have been halted on a circuit breaker to the upside, with the stock now up by 50.1%.

Portfolio Pulse from Happy Mohamed

July 28, 2023 | 3:35 pm

Several healthcare stocks experienced significant movement in Thursday's after-market session. Gainers included SIGA Technologies, Homology Medicines, INVO Bioscience, AIM ImmunoTech, electroCore, and vTv Therapeutics. Losers included Tonix Pharmaceuticals, Femasys, Mettler-Toledo Intl, Inozyme Pharma, MyMD Pharmaceuticals, and Reshape Lifesciences.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 9:32 pm

During Thursday's intraday session, several healthcare stocks experienced significant movements. Femasys (FEMY), Mallinckrodt (MNK), Cutera (CUTR), Evolus (EOLS), INVO Bioscience (INVO), and Talkspace (TALK) saw their stocks rise, with Femasys leading the gainers with a 146.9% increase. On the other hand, Mersana Therapeutics (MRSN), Asensus Surgical (ASXC), Biohaven (BHVN), Bluejay Diagnostics (BJDX), Armata Pharmaceuticals (ARMP), and icad (ICAD) saw their stocks fall, with Mersana Therapeutics leading the losers with a 78.3% decrease.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 5:31 pm

INVO BioScience has announced a 1-for-20 reverse stock split, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 4:58 pm

INVO BioScience has announced a 1-for-20 reverse stock split, which will be effective pre-market opening on July 28.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 1:28 pm

In Wednesday's pre-market session, several health care stocks showed significant movement. Tilray Brands, Talaris Therapeutics, Aspira Womens Health, cbdMD, G Medical Innovations, and Erasca saw increases, while INVO Bioscience, XTL Biopharmaceuticals, Fresh Tracks Therapeutics, Armata Pharmaceuticals, PaxMedica, and BrainsWay experienced decreases.

Portfolio Pulse from Benzinga Insights

July 26, 2023 | 1:06 pm

In Tuesday's after-market session, several health care stocks saw significant movement. Gainers included 9 Meters Biopharma (NASDAQ:NMTR), ViewRay (NASDAQ:VRAY), Plus Therapeutics (NASDAQ:PSTV), PAVmed (NASDAQ:PAVM), CollPlant Biotechnologies (NASDAQ:CLGN), and NRX Pharmaceuticals (NASDAQ:NRXP). Losers included INVO Bioscience (NASDAQ:INVO), Adial Pharmaceuticals (NASDAQ:ADIL), Etao International Co (NASDAQ:ETAO), Fresh Tracks Therapeutics (NASDAQ:FRTX), Myomo (AMEX:MYO), and ThermoGenesis Holdings (NASDAQ:THMO).

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 9:32 pm

The article lists the stocks that gained and lost the most in Monday's mid-day session. Tupperware Brands Corporation (TUP), Vinco Ventures (BBIG), and Spark Networks (LOV) were among the top gainers, while AppHarvest (APPH), Kodiak Sciences (KOD), and BioCardia (BCDA) were among the top losers. Ryanair Holdings (RYAAY) shares fell by 8.3% after the company reported quarterly results.

Portfolio Pulse from Lisa Levin

July 24, 2023 | 6:54 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.